Monitoring COVID-19 patients in Luxembourg to predict disease severity
Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis
Luxembourg Institute of Health · NCT04380987
This study is tracking COVID-19 patients in Luxembourg for two weeks to see what factors might lead to more severe illness compared to those with milder symptoms.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Luxembourg Institute of Health (other gov) |
| Locations | 1 site (Luxembourg) |
| Trial ID | NCT04380987 on ClinicalTrials.gov |
What this trial studies
This observational study follows COVID-19 positive patients in Luxembourg for 14 days post-diagnosis, monitoring their health and symptoms digitally. Participants will complete daily questionnaires, and biological samples will be collected to analyze factors associated with disease severity. The study aims to identify risk factors for severe COVID-19 by comparing symptomatic patients with severe disease to those with mild cases managed at home. Follow-up evaluations will occur at weeks 3 and 4, and monthly for up to 12 months to assess long-term consequences.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have tested positive for COVID-19.
Not a fit: Patients who do not understand French or German or are already participating in another interventional COVID-19 study may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve understanding of COVID-19 severity factors, leading to better patient management and outcomes.
How similar studies have performed: Other studies have successfully utilized similar observational approaches to understand COVID-19, making this study a valuable addition to existing research.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * SARS-CoV-2 infection as determined by PCR, performed by one of the certified laboratories in Luxembourg * Signed informed consent form * Age ≥18 years old * Hospitalized or at home Exclusion Criteria: * Patients not understanding French or German * Patients already included in an interventional study on Covid-19 (Discovery or other)
Where this trial is running
Luxembourg
- Luxembourg Institute of Health — Luxembourg, Luxembourg (RECRUITING)
Study contacts
- Study coordinator: Aurelie Fischer, MS
- Email: aurelie.fischer@lih.lu
- Phone: 00352621328591
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Covid19, Severity factors, Patient stratification, Digital